tiprankstipranks
bioMerieux SA (FR:BIM)
:BIM
France Market

bioMerieux (BIM) Income Statement

Compare
6 Followers

bioMerieux Income Statement

Last quarter (Q2 2024), bioMerieux's total revenue was €1.90B, an increase of 14.71% from the same quarter last year. In Q2, bioMerieux's net income was €215.30M. See bioMerieux’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 3.98B€ 3.67B€ 3.59B€ 3.38B€ 3.12B
Gross Profit
€ 2.22B€ 2.06B€ 1.96B€ 1.97B€ 1.74B
Operating Expenses
€ 1.60B€ 1.62B€ 1.40B€ 1.20B€ 1.19B
Depreciation and Amortization
€ 325.20M€ 259.40M€ 257.60M€ 220.40M€ 228.40M
EBITDA
€ 909.50M€ 827.60M€ 811.90M€ 977.80M€ 747.70M
Operating Income
€ 614.70M€ 439.10M€ 559.80M€ 768.00M€ 551.20M
Other Income/Expenses
€ -35.30M€ -1.60M€ 20.70M€ -9.80M€ -26.80M
Pretax Income
€ 579.40M€ 437.50M€ 550.20M€ 748.30M€ 494.40M
Net Income
€ 432.20M€ 357.60M€ 452.40M€ 601.10M€ 404.40M
Per Share Metrics
Basic EPS
€ 3.67€ 3.03€ 3.84€ 5.08€ 3.42
Diluted EPS
€ 3.64€ 3.01€ 3.82€ 5.06€ 3.41
Weighted Average Shares Outstanding
117.77M 118.05M 117.95M 118.27M 118.15M
Weighted Average Shares Outstanding (Diluted)
118.74M 118.80M 118.44M 118.89M 118.65M
Currency in EUR

bioMerieux Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis